Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2017-12-09 2017-12-08
Drug Identification Number 02457954 02457954
Brand name MINT-LEVOCARB MINT-LEVOCARB
Common or Proper name Levodopa/Carbidopa Levodopa/Carbidopa
Company Name MINT PHARMACEUTICALS INC MINT PHARMACEUTICALS INC
Ingredients CARBIDOPA LEVODOPA CARBIDOPA LEVODOPA
Strength(s) 10MG 100MG 10MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 count bottles 100 count bottles
ATC code N04BA N04BA
ATC description DOPAMINERGIC AGENTS DOPAMINERGIC AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-12-08 2017-12-08
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments